A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Lineage Cell Therapeutics Inc’s current trading price is -64.32% away from its 52-week high, while its distance from the 52-week low is 19.42%. The
The market performance of Lineage Cell Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.61 on 03/28/24, while the lowest value for the same duration was $0.48 on 12/30/24. 52-week price history
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Lineage Cell Therapeutics Inc’s current trading price is -57.17% away from its 52-week high, while its distance from the 52-week low is
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 31.04%. However, over
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Lineage Cell Therapeutics Inc’s current trading price is -58.07% away from its 52-week high, while its distance from the 52-week low is
All rights reserved © 2024, Powered By Smart TechOne
